Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24346,991,1.54 [1.29-1.84],1.830810159886525e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24259,196,2.14 [1.52-3.02],1.4948504252277303e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18561,773,1.69 [1.38-2.09],7.198778776272662e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25144,85,2.29 [1.41-3.72],0.0008004360426083
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27000,121,1.83 [1.22-2.76],0.0035756110013074
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26951,72,2.11 [1.34-3.33],0.001296191905039
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27756,77,2.17 [1.38-3.41],0.000844100798986
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26549,438,1.64 [1.27-2.11],0.0001311250021757
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26242,131,1.84 [1.19-2.85],0.0059173197786236
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26415,304,1.65 [1.22-2.24],0.0010849051076551
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23336,674,1.55 [1.26-1.89],2.634578011466522e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22714,52,2.47 [1.59-3.82],5.392133805244322e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26477,276,0.64 [0.45-0.89],0.0092125866924084
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24644,424,1.74 [1.37-2.22],6.392018998383247e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27325,99,2.16 [1.41-3.30],0.0003914483681754
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23139,926,1.76 [1.46-2.13],6.351180500340179e-09
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26025,124,3.46 [2.43-4.92],4.7122753344921495e-12
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26011,110,3.27 [2.30-4.66],4.702028523782155e-11
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26324,423,2.72 [2.12-3.48],3.236398922202447e-15
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26314,413,2.70 [2.10-3.47],7.234539820207757e-15
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22947,734,1.82 [1.47-2.26],4.2337966918465764e-08
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22894,681,1.74 [1.40-2.18],1.0222495114431868e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Any mental disorder,23518,626,1.53 [1.24-1.90],7.607322042003356e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23012,120,2.55 [1.78-3.67],4.115489292544245e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27658,80,2.64 [1.76-3.96],2.7517834823364708e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27699,48,2.62 [1.58-4.35],0.0001931285366729
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26429,38,2.36 [1.35-4.12],0.0024353154903714
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27850,38,2.31 [1.31-4.09],0.0038444738850959
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22930,38,2.35 [1.36-4.05],0.0021338048279507
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Neurological diseases,24046,1649,1.40 [1.22-1.61],1.3244725828555262e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21993,183,2.20 [1.52-3.17],2.653408597376557e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27701,152,2.11 [1.50-2.97],1.8507612177452872e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26547,433,1.90 [1.51-2.40],4.8668925713867486e-08
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Epilepsy,26255,141,2.16 [1.54-3.05],1.0127883387848076e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other sleep disorders,26213,99,2.16 [1.34-3.47],0.0015768101217699
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Sleep apnoea,27477,71,2.11 [1.30-3.43],0.0026720826865505
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter VI Diseases of the nervous system,Other neurological diseases,27400,125,1.79 [1.19-2.68],0.0049815874486241
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23712,178,1.65 [1.15-2.38],0.0069239626405418
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26834,189,1.77 [1.27-2.49],0.0008731922318289
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27625,36,3.27 [2.08-5.14],2.8501858328826775e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1803,36,4.31 [1.72-10.82],0.0018480494431688
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25858,36,3.30 [2.11-5.17],1.940820224701104e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27047,96,2.06 [1.34-3.14],0.0008907491039146
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20535,2840,1.27 [1.12-1.44],0.0002179310776127
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27313,77,0.22 [0.12-0.41],1.7061202757447114e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21563,2094,1.46 [1.27-1.68],1.5562428708388908e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertension,21585,2116,1.46 [1.27-1.68],1.1186065083636969e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16912,283,0.29 [0.20-0.41],5.620947070247622e-12
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22664,2130,1.29 [1.14-1.47],6.729248741484371e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24896,1176,1.38 [1.18-1.63],9.311087974382094e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Early onset COPD,26818,158,1.91 [1.29-2.81],0.0011330154422654
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25814,1011,1.34 [1.13-1.59],0.0008476159946691
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Asthma,20708,1011,1.43 [1.20-1.71],7.722978144933489e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20515,1011,1.42 [1.19-1.70],0.0001217739879896
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20692,995,1.43 [1.20-1.71],9.311654980745008e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27567,84,2.07 [1.31-3.27],0.0018755675754859
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,26086,63,2.78 [1.75-4.41],1.3907516642749275e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27643,63,2.76 [1.75-4.35],1.3352603669760974e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26079,56,3.08 [1.90-4.99],4.57343217013122e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26707,92,2.03 [1.33-3.07],0.0009143917722368
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19305,6081,1.30 [1.19-1.43],8.801011783980156e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27323,482,1.48 [1.17-1.88],0.0012128951744186
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23197,2350,1.23 [1.09-1.40],0.0008088146531592
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24726,971,1.28 [1.07-1.53],0.0077076143866043
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20269,396,1.57 [1.20-2.07],0.0012098399335733
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Constipation,26156,352,1.51 [1.13-2.00],0.0047869289269248
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of liver,27086,106,1.87 [1.21-2.90],0.0050476460371059
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26484,312,1.47 [1.10-1.97],0.0091296064249684
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24675,1634,1.33 [1.15-1.53],0.0001165869895252
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27054,328,1.54 [1.16-2.05],0.0028678567381933
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26796,70,2.02 [1.22-3.36],0.0064241626152237
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27616,55,2.01 [1.23-3.27],0.0049918066946065
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27613,52,2.16 [1.35-3.45],0.0012658448563506
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19633,4448,1.28 [1.16-1.41],7.695010101524779e-07
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21400,2556,1.22 [1.09-1.38],0.0009241874511436
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25032,1345,1.26 [1.08-1.47],0.0040393332358167
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19053,209,2.15 [1.54-2.99],5.7663327802129e-06
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19366,522,1.51 [1.19-1.92],0.0007825683522056
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27307,201,1.96 [1.43-2.67],2.416141983133081e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27325,184,1.98 [1.44-2.73],2.937800706979896e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19342,498,1.37 [1.08-1.74],0.0099229836996844
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20779,299,1.53 [1.11-2.10],0.0098252146284148
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27057,223,1.77 [1.28-2.44],0.0005428993639292
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26928,94,2.12 [1.43-3.13],0.0001770498436806
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25397,207,1.98 [1.41-2.78],8.332072351602976e-05
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25567,38,2.79 [1.56-5.00],0.0005722768902445
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25578,49,4.07 [2.53-6.55],7.174905578642914e-09
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25573,44,2.47 [1.37-4.45],0.0027543227119089
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25641,1268,1.24 [1.05-1.45],0.0090859341341217
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,27782,469,1.39 [1.08-1.77],0.0091250626671309
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22150,1350,1.26 [1.08-1.47],0.0035589105647856
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27884,885,0.59 [0.48-0.72],2.0099117851635058e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27889,1203,0.62 [0.52-0.75],2.260216992560638e-07
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27714,232,0.61 [0.43-0.88],0.0078607598569888
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27202,203,0.55 [0.38-0.80],0.0020705911434106
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27250,251,0.63 [0.45-0.89],0.009234785341157
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27137,138,0.50 [0.31-0.79],0.0029392922292217
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27152,153,0.44 [0.28-0.69],0.0002739625634227
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26920,234,0.56 [0.39-0.80],0.0015424307330002
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27124,438,0.68 [0.52-0.89],0.0051119397103642
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27359,673,0.68 [0.54-0.86],0.0009340087951885
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27908,173,0.53 [0.35-0.80],0.0023832948332648
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26445,132,0.44 [0.28-0.71],0.0006398502194795
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27916,338,0.48 [0.36-0.65],1.703126957161446e-06
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27836,258,0.46 [0.32-0.64],6.534194397733706e-06
